- Home Page
- Biomarker Testing
- Development Platforms
- Molecular Pathways
-
Investigational Therapies
- Ipatasertib Results
- Mosunetuzumab Results
- glofitamab Results
- Atezolizumab (anti-PDL1 MAb)
- CD19x4-1BBL
- Venetoclax (BCL-2 inhibitor)
- Simlukafusp alfa (FAP x IL2v)
- HER2 x CD3
- iNeST
- Cevostamab
- PD-1 x TIM3
- SERD (3)
- Tiragolumab (anti-TIGIT)
- GDC-0077
- IL15/IL15Ra-Fc
- Cibisatamab (CEA x CD3)
- TLR7 agonist (4)
- PD-1 x IL2v
- PD-1 x LAG3
- CD25 MAb
- BCMA x CD16a
- KRAS G12C
- New Molecular Entity
- Pralsetinib (RET inhibitor)
- Clinical Trials
- Resources
- Registration
- Contact Us
- Copyright
- Search
- About Us